104 results
8-K
EX-3.1
ARAV
Aravive Inc
3 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
be adjourned, from time to time, either by the chairman of the meeting or by vote of the holders of a majority of the shares represented thereat … the election of directors, the affirmative vote of the majority of shares present in person, by remote communication, if applicable, or represented by proxy
DEFR14A
ARAV
Aravive Inc
22 Sep 23
Revised proxy
5:04pm
of a majority of the voting power of the outstanding stock of the corporation entitled to vote thereon, before proceeding with a sale of all … , in the aggregate, 26,865,750 shares of our common stock, representing 43.3% of our outstanding shares as of August 3, 2023, including a majority of the members
424B5
89xoigere pemez3
28 Jun 23
Prospectus supplement for primary offering
6:01am
8-K
EX-99.1
yb9dkq
10 May 23
Aravive Reports First Quarter 2023 Financial Results and Provides Corporate Updates
4:05pm
CORRESP
5rxr6fjx17
10 May 23
Correspondence with SEC
12:00am
424B3
f9zal1jc3f 987uv0r2d
29 Nov 22
Prospectus supplement
4:05pm
8-K
EX-99.1
vab1mjwoc99 9h09
29 Nov 22
Aravive Announces Fast Track Designation of Batiraxcept for Treatment of ccRCC
7:05am
8-K/A
EX-10.1
9k1jw7h
28 Oct 22
Other Events
4:05pm
8-K
EX-10.1
f34jflt8c obm5wl8w70
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm